EquityFlow
›
Companies
› KetoSwiss
KetoSwiss
Biotech
· Basel, CH
Develops ketone-based "brain fuels" (MigraKet) for migraine and neurological disorders.
Funding history
Date
Round
Amount
Aug 2023
Series A
Basel-based biotech KetoSwiss raised a $4.8M pre-Series A to develop its medical food for migraine.
$4.8M
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →